Last Updated : January 25, 2024
Details
| Call for patient/clinician input open | 17-Nov-22 |
|---|---|
| Call for patient/clinician input closed | 13-Jan-23 |
| Clarification: - Patient input submission received from the Colorectal Cancer Resource & Action Network (CCRAN | |
| Submission received | 15-Dec-22 |
| Submission accepted | 06-Jan-23 |
| Review initiated | 09-Jan-23 |
| Clarification: - Submission temporarily suspended - Additional information has been received and the temporary suspension of the review has been lifted | |
| Draft Canada's Drug Agency review report(s) provided to sponsor for comment | 21-Jun-23 |
| Deadline for sponsors comments | 30-Jun-23 |
| Canada's Drug Agency review report(s) and responses to comments provided to sponsor | 27-Jul-23 |
| Expert committee meeting (initial) | 09-Aug-23 |
| Draft recommendation issued to sponsor | 22-Sep-23 |
| Draft recommendation posted for stakeholder feedback | 05-Oct-23 |
| End of feedback period | 20-Oct-23 |
| Final recommendation issued to sponsor and drug plans | 03-Nov-23 |
| Final recommendation posted | 22-Nov-23 |
| Deadline for sponsor to submit redaction requests on draft Canada's Drug Agency review report(s) | 20-Nov-23 |
| Canada's Drug Agency review report(s) posted | 25-Jan-24 |